• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有“干性”相关标志物表达的人肝细胞癌:角蛋白 19 的表达与预后不良相关。

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

机构信息

Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.

DOI:10.1002/hep.24559
PMID:22045674
Abstract

UNLABELLED

There is a recently proposed subtype of hepatocellular carcinoma (HCC) that is histologically similar to usual HCC, but characterized by the expression of "stemness"-related markers. A large-scale study on two different cohorts of HCCs was performed to investigate the clinicopathologic features and epithelial-mesenchymal transition (EMT)-related protein expression status of this subtype of HCCs. The expression status of stemness-related (e.g., keratin 19 [K19], cluster of differentiation [CD]133, epithelial cell adhesion molecule [EpCAM], and c-kit) and EMT-related markers (e.g., snail, S100A4, urokinase plasminogen activator receptor [uPAR], ezrin, vimentin, E-cadherin, and matrix metalloproteinase [MMP]2) were examined using tissue microarrays from cohort 1 HCCs (n = 137). K19 protein expression in cohort 2 HCCs (n = 237) was correlated with the clinicopathologic parameters and messenger RNA (mRNA) levels of K19, uPAR, VIL2, Snail, Slug, and Twist. K19, EpCAM, c-kit, and CD133 positivity were observed in 18.2%, 35.0%, 34.3%, and 24.8%, respectively. K19 was most frequently expressed in combination with at least one other stemness-related marker (92.0%). K19-positive HCCs demonstrated more frequent major vessel invasion and increased tumor size, compared to K19-negative HCCs (P < 0.05). K19 was most significantly associated with EMT-related protein expression (e.g., vimentin, S100A4, uPAR, and ezrin) (P < 0.05) and a poor prognosis (overall survival: P = 0.018; disease-free survival: P = 0.007) in cohort 1. In cohort 2, HCCs with high K19 mRNA levels demonstrated higher mRNA levels of Snail, uPAR, and MMP2 (P < 0.05). K19-positive HCCs demonstrated more frequent microvascular invasion, fibrous stroma, and less tumor-capsule formation, compared to K19-negative HCCs (P < 0.05). K19 expression was a significant independent predictive factor of poor disease-free survival (P = 0.032).

CONCLUSION

K19 was well correlated with clinicopathologic features of tumor aggressiveness, compared to other stemness-related proteins. K19-positive HCCs showed significantly increased EMT-related protein and mRNA expression, suggesting that they may acquire more invasive characteristics, compared to K19-negative HCCs through the up-regulation of EMT-associated genes.

摘要

目的

最近提出了一种肝细胞癌(HCC)的亚型,其组织学上与普通 HCC 相似,但以“干性”相关标志物的表达为特征。对来自 HCC 的两个不同队列进行了大规模研究,以研究该 HCC 亚型的临床病理特征和上皮-间充质转化(EMT)相关蛋白表达状态。使用来自队列 1 HCC(n=137)的组织微阵列检查了干性相关标志物(例如角蛋白 19 [K19]、分化簇 [CD]133、上皮细胞黏附分子 [EpCAM]和 c-kit)和 EMT 相关标志物(例如 snail、S100A4、尿激酶纤溶酶原激活物受体[uPAR]、ezrin、波形蛋白、E-钙黏蛋白和基质金属蛋白酶 [MMP]2)的表达状态。队列 2 HCC(n=237)的 K19 蛋白表达与临床病理参数和 K19、uPAR、VIL2、Snail、Slug 和 Twist 的信使 RNA(mRNA)水平相关。K19、EpCAM、c-kit 和 CD133 的阳性率分别为 18.2%、35.0%、34.3%和 24.8%。K19 阳性 HCC 与至少一种其他干性相关标志物的组合表达最为频繁(92.0%)。K19 阳性 HCC 与 K19 阴性 HCC 相比,更常发生主要血管侵犯和肿瘤增大(P<0.05)。在队列 1 中,K19 与 EMT 相关蛋白表达(例如波形蛋白、S100A4、uPAR 和 ezrin)(P<0.05)和不良预后(总生存:P=0.018;无病生存:P=0.007)最显著相关。在队列 2 中,高 K19 mRNA 水平的 HCC 表现出更高的 Snail、uPAR 和 MMP2 的 mRNA 水平(P<0.05)。与 K19 阴性 HCC 相比,K19 阳性 HCC 更常发生微血管侵犯、纤维性基质和更少的肿瘤包膜形成(P<0.05)。K19 表达是无病生存不良的显著独立预测因子(P=0.032)。

结论

与其他干性相关蛋白相比,K19 与肿瘤侵袭性的临床病理特征密切相关。与 K19 阴性 HCC 相比,K19 阳性 HCC 表现出明显增加的 EMT 相关蛋白和 mRNA 表达,提示它们可能通过 EMT 相关基因的上调获得更具侵袭性的特征。

相似文献

1
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.具有“干性”相关标志物表达的人肝细胞癌:角蛋白 19 的表达与预后不良相关。
Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.
2
Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.肝细胞癌中含转化酸性卷曲螺旋蛋白3(TACC3)的过表达与“干性”、上皮-间质转化相关标志物表达及预后不良有关。
Tumour Biol. 2016 Jan;37(1):393-403. doi: 10.1007/s13277-015-3810-7. Epub 2015 Jul 29.
3
Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.端粒长度、TERT 和具有“干性”相关标志物表达的肝细胞癌中的庇护素复合物蛋白。
J Hepatol. 2013 Oct;59(4):746-52. doi: 10.1016/j.jhep.2013.05.011. Epub 2013 May 14.
4
Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.在高表达 CD133-人源的乙型肝炎病毒相关性肝细胞癌中,侵袭和 EMT 相关基因上调及细胞培养研究。
Exp Mol Pathol. 2011 Feb;90(1):66-73. doi: 10.1016/j.yexmp.2010.10.003. Epub 2010 Oct 20.
5
Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.干性标志物(CD133和EpCAM)在肝细胞癌预后中的表达
Histopathology. 2014 Jun;64(7):935-50. doi: 10.1111/his.12342. Epub 2014 Feb 7.
6
Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.表达“干性”相关标志物的肝细胞癌:临床病理特征
Dig Dis. 2014;32(6):778-85. doi: 10.1159/000368021. Epub 2014 Oct 29.
7
Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.γ-平滑肌肌动蛋白表达与肝细胞癌的上皮-间质转化及干细胞样特性相关。
PLoS One. 2015 Jun 25;10(6):e0130559. doi: 10.1371/journal.pone.0130559. eCollection 2015.
8
Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.Yes 相关蛋白 1 在具有干性和肝细胞胆管细胞癌特征的肝癌中的高表达。
PLoS One. 2013 Sep 24;8(9):e75449. doi: 10.1371/journal.pone.0075449. eCollection 2013.
9
Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.角蛋白 19,人肝癌中的癌症干细胞标志物。
Clin Cancer Res. 2015 Jul 1;21(13):3081-91. doi: 10.1158/1078-0432.CCR-14-1936. Epub 2015 Mar 27.
10
MRI features of hepatocellular carcinoma expressing progenitor cell markers.表达祖细胞标志物的肝细胞癌的 MRI 特征。
Liver Int. 2012 Mar;32(3):430-40. doi: 10.1111/j.1478-3231.2011.02640.x. Epub 2011 Sep 13.

引用本文的文献

1
Surgical and Oncological Outcomes of Conversion Surgery After Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Locally Advanced Hepatocellular Carcinoma.肝动脉灌注化疗后对初始不可切除的局部晚期肝细胞癌进行转化手术的外科和肿瘤学结局
Ann Gastroenterol Surg. 2025 May 7;9(5):1075-1085. doi: 10.1002/ags3.70034. eCollection 2025 Sep.
2
Histological and Molecular Evaluation of Liver Biopsies: A Practical and Updated Review.肝活检的组织学和分子评估:实用且最新的综述
Int J Mol Sci. 2025 Aug 10;26(16):7729. doi: 10.3390/ijms26167729.
3
Whole-lesion iodine map histogram analysis combined with focal ROI iodine concentrations for preoperative prediction of cytokeratin 19-positive hepatocellular carcinoma.
全病灶碘图直方图分析联合局部感兴趣区碘浓度用于术前预测细胞角蛋白19阳性肝细胞癌
Abdom Radiol (NY). 2025 Jul 11. doi: 10.1007/s00261-025-05116-2.
4
Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma.多组学和单细胞方法揭示了肝细胞癌的分子亚型和关键细胞相互作用。
Front Pharmacol. 2025 May 22;16:1605162. doi: 10.3389/fphar.2025.1605162. eCollection 2025.
5
Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma.基于三维磁共振弹性成像的硬度评估肝细胞癌中Ki67增殖指数和细胞角蛋白-19的状态
Eur Radiol. 2025 Feb 18. doi: 10.1007/s00330-025-11375-w.
6
CK19 protein expression: the best cutoff value on the prognosis and the prognosis model of hepatocellular carcinoma.细胞角蛋白19蛋白表达:肝细胞癌预后的最佳临界值及预后模型
BMC Cancer. 2025 Jan 10;25(1):55. doi: 10.1186/s12885-024-13399-9.
7
Isolation and identification of patient-derived liver cancer stem cells and development of personalized treatment strategies.患者来源肝癌干细胞的分离鉴定及个体化治疗策略的建立。
J Transl Med. 2024 Nov 18;22(1):1036. doi: 10.1186/s12967-024-05870-9.
8
Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy: A Narrative Review.中间丝在乳腺癌进展中的作用及癌症治疗的潜在生物标志物:一项叙述性综述
Breast Cancer (Dove Med Press). 2024 Oct 14;16:689-704. doi: 10.2147/BCTT.S489953. eCollection 2024.
9
Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization.CK19 阳性对接受经肝动脉化疗栓塞治疗的早期复发性肝细胞癌患者的预后意义。
BMC Gastroenterol. 2024 Oct 3;24(1):347. doi: 10.1186/s12876-024-03417-2.
10
Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis.癌症干细胞标志物表达对肝细胞癌不良结局的诊断价值及其与预后的关联:一项贝叶斯网络荟萃分析
Oncol Lett. 2024 Sep 6;28(5):536. doi: 10.3892/ol.2024.14669. eCollection 2024 Nov.